Deutsche Bank raised the firm’s price target on HealthEquity to $85 from $72 and keeps a Buy rating on the shares following meetings with managemewbt.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HQY:
- HealthEquity price target raised to $110, named a ‘Best Idea’ at Guggenheim
- Enphase Energy upgraded, Brighthouse downgraded: Wall Street’s top analyst calls
- Baird upgrades HealthEquity on ‘multi-decade compounder’ potential
- HealthEquity upgraded to Outperform from Neutral at Baird
- UPDATE: Conduent’s BenefitWallet HSA Portfolio Moving to HealthEquity
Questions or Comments about the article? Write to editor@tipranks.com